Shareholders Foundation, Inc.

SPX Options, VIX Options, VIX Futures or VIX ETPs Investor Alert: Lawsuit Against Cboe Global Markets, Inc Filed

A lawsuit was filed on behalf of investors in SPX Options, VIX Options, VIX Futures or VIX ETPs over alleged securities laws violations.

 

San Diego, CA -- (SBWIRE) -- 04/18/2018 -- An investor filed a lawsuit on behalf of investors who held or traded S&P 500 ("SPX") option contracts ("SPX Options"), CBOE Volatility Index ("VIX") option contracts ("VIX Options"), futures based on the VIX ("VIX Futures"), or VIX Exchange Traded Products ("VIX ETPs") on exchanges run by Cboe Global Markets, Inc. (formerly known as CBOE Holdings, Inc.) and its affiliates ("CBOE") during the following time periods:

From March 26, 2004 to the present in the case of VIX Futures and SPX Options;

From February 24, 2006 to the present in the case of VIX Options; and

From August 2008 to the present in the case of VIX ETPs.

Those who held or traded S&P 500 (option contracts, CBOE Volatility Index option contracts, futures based on the VIX, or VIX Exchange Traded Products on exchanges run by Cboe Global Markets, Inc. (formerly known as CBOE Holdings, Inc.) and its affiliates during the time periods stated above, have certain options and for certain investors are short and strict deadlines running. Deadline: June 4, 2018. Those investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges CBOE participated with others to manipulate the VIX "fear gauge" in a systematic manner during the 2004 to 2018 timeframe. The plaintiff claims that this alleged improper manipulation caused economic damages to investors who traded in VIX futures, options and certain other VIX derivatives and that as a consequence of these activities, the complaint alleges that CBOE and a few of its preferred traders violated the Securities Exchange Act of 1934, the Commodity Exchange Act and the Sherman Act.

CBOE runs the exclusive exchange for core VIX financial instruments in the United States and is not permitted to run the VIX market in a "rigged" manner, as the complaint alleges.

The complaint alleges that in February 2018, a whistleblower, who reportedly had held senior positions at some of the largest investment firms in the world, disclosed widespread manipulation of the VIX. After these disclosures were made public, one former regulatory official responded that the whisteblower's claim "rings true." Another former regulatory official reportedly explained it was "quite clear" that the VIX can be manipulated and that CBOE "should have sprung in to action" to bring any manipulation to a halt.

The complaint's forensic quantitative analysis corroborates the whistleblower's claim. It also corroborates academic work that was published in a prestigious, peer-reviewed academic journal in May 2017, raising questions about whether the VIX was being manipulated and suggesting various means of demonstrating that it was, in fact, manipulated.

As alleged in the complaint, plaintiff's recently completed forensic analyses confirm that the VIX was manipulated during the time periods stated above.

The plaintiff alleges that the analyses also show, however, that the VIX manipulation abated to some degree in the immediate aftermath of the May 2017 peer-reviewed academic article mentioned above.

The complaint alleges these May 2017 changes in the trading patterns underlying the VIX market tend to show defendants' culpable state of mind because, in essence, they changed their trading behavior when faced with the risk being discovered.

These and other facts set forth in the complaint support the allegations that CBOE and its preferred traders were "banging the VIX close" in a systematic manner, during the time periods stated above. CBOE allegedly conferred financial benefits and special trading privileges to a few traders who, in exchange for driving higher trading volume (and fees) for CBOE, enjoyed special privileges that allowed them to game the VIX and manipulate VIX derivative prices to the detriment of the Class. CBOE, in turn, benefited financially from the manipulation as VIX products were its "flagship" products, which generated much of CBOE's revenues, as the complaint alleges.

Those who held or traded S&P 500 (option contracts, CBOE Volatility Index option contracts, futures based on the VIX, or VIX Exchange Traded Products on exchanges run by Cboe Global Markets, Inc. (formerly known as CBOE Holdings, Inc.) and its affiliates during the time periods stated above have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com